Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Relative Age and Passing Performance in Pre-adolescent Football Players (RAE-LSPT)

21 luglio 2026 aggiornato da: Édison Andrés Pérez Bedoya, Federal University of Vicosa

Relative Age and Passing Performance in Pre-adolescent Football Players: A Cross-Sectional Study Using the Loughborough Soccer Passing Test

This completed cross-sectional observational study examined whether relative age within an annual selection cycle was associated with passing performance in pre-adolescent football players. Participants were classified by birth month, birth quarter and birth semester. Passing performance was assessed using the Loughborough Soccer Passing Test, in which players completed 16 passes to colour-coded targets as quickly and accurately as possible. Total performance time combined movement time, time penalties for errors and time bonuses for accurate passes. The study evaluated the distribution of players across the selection year and the association between relative age and passing-test performance while accounting for the two chronological birth cohorts represented in the sample.

Panoramica dello studio

Stato

Completato

Condizioni

Descrizione dettagliata

Annual age grouping in youth football can create a relative age effect, characterised by the over-representation of players born earlier in the selection year. This pattern is often attributed to temporary developmental advantages, but it is unclear whether earlier-born pre-adolescent players also demonstrate superior technical performance.

The study used a cross-sectional observational design in a youth football development programme in Bello, Colombia. The source cohort contained 61 participant records. Birth month was used to classify players into four relative-age quarters: Q1 (January-March), Q2 (April-June), Q3 (July-September) and Q4 (October-December), and into two semesters: H1 (January-June) and H2 (July-December).

Passing performance was measured with the Loughborough Soccer Passing Test. Players were scheduled to complete two trials separated by five minutes. Each trial comprised 16 externally cued passes to four colour-coded target areas. Movement time was adjusted by adding penalties for inaccurate execution or protocol violations and subtracting bonuses for striking the central target strip. Lower total performance time indicated better performance. The primary technical outcome was the mean total performance time across available trials. Sensitivity outcomes included Trial 1 and the best trial.

The primary analysis estimated the association between birth month and LSPT total performance time after adjustment for birth cohort. Additional analyses examined representation by quarter and semester and agreement between the two LSPT trials. Data collection was completed in 2017. The study is being registered retrospectively in 2026 to improve transparency and support public sharing of the anonymised dataset and analysis materials.

Tipo di studio

Osservativo

Iscrizione (Effettivo)

61

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

  • Colombia
    • Antioquia
      • Guarne, Antioquia, Colombia, 054080
        • Tecnológico de Antioquia

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Bambino

Accetta volontari sani

N/A

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

Pre-adolescent football players enrolled in a youth football development programme in Bello, Antioquia, Colombia. Participants were recruited from the available programme roster using a non-probability, programme-based sample. The study included players from two chronological birth cohorts and classified them according to position within the annual selection year.

Descrizione

Inclusion Criteria:

  • Registered or actively participating in the selected youth football development programme in Bello, Colombia during the assessment period.
  • Date of birth available in the programme roster.
  • Able to undertake the football passing assessment.
  • Written parent or legal guardian consent and child assent.

Exclusion Criteria:

  • Acute injury, illness or medical restriction preventing safe completion of the LSPT [retain only if this was an actual criterion].
  • Unable to complete the required familiarisation or test procedure.
  • Missing date-of-birth information.
  • No valid LSPT trial available for inclusion in the primary analytical sample.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

Coorti e interventi

Gruppo / Coorte
Group 1
Q1 - Players born from January to March
Group 2
Q2 - Players born from April to June
Group 3
Q3 - Players born from July to September
Group 4
Q4 - Players born from October to December

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Mean LSPT total performance time
Lasso di tempo: Day 1
Mean of all available LSPT trial total performance times, expressed in seconds. For each trial, total performance time was calculated as movement time plus penalty time minus bonus time. Lower values indicate better performance.
Day 1
Number of participants in each relative-age quarter
Lasso di tempo: Baseline
Count of participants classified as Q1 (January-March), Q2 (April-June), Q3 (July-September) or Q4 (October-December), based on the date of birth recorded in the programme roster.
Baseline

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
LSPT Trial 1 total performance time
Lasso di tempo: Day 1
Trial 1 movement time plus penalty time minus bonus time, expressed in seconds.
Day 1
Best LSPT total performance time
Lasso di tempo: Day 1
Lowest total performance time recorded across the participant's available LSPT trials, expressed in seconds. Two trials were scheduled five minutes apart.
Day 1
Number of participants in each relative-age semester
Lasso di tempo: Baseline
Count of participants classified as H1 (January-June) or H2 (July-December), based on the date of birth recorded in the programme roster.
Baseline
Difference between Trial 2 and Trial 1 total performance time
Lasso di tempo: Day 1
Trial 2 total performance time minus Trial 1 total performance time, expressed in seconds, among participants who completed both trials. The two trials were scheduled five minutes apart.
Day 1

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Federal University of Vicosa

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

15 gennaio 2024

Completamento primario (Effettivo)

15 gennaio 2024

Completamento dello studio (Effettivo)

20 marzo 2024

Date di iscrizione allo studio

Primo inviato

16 luglio 2026

Primo inviato che soddisfa i criteri di controllo qualità

21 luglio 2026

Primo Inserito (Effettivo)

27 luglio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

27 luglio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

21 luglio 2026

Ultimo verificato

1 luglio 2026

Maggiori informazioni

Termini relativi a questo studio

Parole chiave

Altri numeri di identificazione dello studio

  • RAE-LSPT-2017-01

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

The de-identified individual participant data underlying the results reported in the associated article will be made publicly available in Zenodo. The shared materials will include the participant-level analytical dataset, data dictionary, metadata, and reproducible analysis code. Names, identity-document numbers, exact dates of birth, contact information, and any participant re-identification key will not be shared. Data will become available when the Zenodo record is released, no later than publication of the primary article, and will remain available indefinitely under a Creative Commons Attribution 4.0 International licence. Access will be open and will not require submission or approval of a research proposal.

Periodo di condivisione IPD

Data will be available from the public release of the Zenodo record, no later than publication of the primary article, and will remain available indefinitely.

Criteri di accesso alla condivisione IPD

The data and supporting materials will be publicly accessible through Zenodo without the need for a formal request, research proposal, data-use agreement, or approval by the study investigators.

Tipo di informazioni di supporto alla condivisione IPD

  • STUDIO_PROTOCOLLO
  • LINFA
  • CODICE_ANALITICO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi